Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Change Regulations Hinder Pharma Innovation According to PDA PAC iAM Survey

Parenteral Drug Association
Posted on: 31 Jul 17

BETHESDA, Md., July 28, 2017 /PRNewswire-USNewswire/ -- The Parenteral Drug Association (PDA) today announces the results of its pharma/biopharma survey regarding the impact of national-level post-approval change regulations on company's ability to innovate. Respondents nearly unanimously (97%) identified these regulations as hurting the innovation and holding back technological progress. PDA's Task Force on Post-Approval Changes: Innovation for Availability of Medicines (PAC iAM), conducted the survey.

"It is unavoidable in the long commercial life of drug products for companies to make manufacturing changes, both to continually improve processes and to address normal issues," said Richard Johnson, PDA President. "The PAC iAM task force strives to open a global dialogue on deleterious effects of a non-harmonized post-approval changes regulatory environment with the ultimate goal of finding a science-based, risk-based solution."

To that end, the PAC iAM is holding a workshop September 13-14, following the 2017 PDA/FDA Joint Regulatory Conference, at the Renaissance Washington Hotel (Washington, DC). The group is also preparing a PDA Technical Report on post-approval changes that will present practical aspects of PAC management and include representative protocols for different types of changes.

More on the PAC iAM task force's efforts can be found at https://www.pda.org/conference/pac-iam/home.

About PDA – Connecting People, Science and Regulation®

The Parenteral Drug Association (PDA) is the leading global provider of science, technology and regulatory information and education for the pharmaceutical and biopharmaceutical community. Founded in 1946 as a nonprofit organization, PDA is committed to developing scientifically sound, practical technical information and resources to advance science and regulation through the expertise of its 10,000 members worldwide. Go to http://www.pda.org/footer/about-pda to learn more.

Media Inquiries: Walt Morris, 301-656-5900, x. 148; morris@pda.org

Editor's Details

Mike Wood
PharmiWeb.com
www.pharmiweb.com
editor@pharmiweb.com

Last updated on: 31/07/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.